UPDATES
Industry-Friendly FDA Leadership
Regulatory Process Streamlining
Increased Use of Real-World Evidence
Potential Device Reclassification
Political Influence on FDA Decisions
Balancing Speed with Safety
Opportunities and Risks for Orthopedic Companies
In the early Donald Trump's presidency, we've seen significant shifts at the FDA that align with expectations of a more industry-friendly approach. The appointment of Marty Makary as FDA Commissioner signals a potential pivot towards policies that favor speed and innovation over traditional safety checkpoints. One of the immediate actions...
